The selection of a primary container may be critical to drug safety and efficacy. Accelerated by the COVID-19 pandemic, newly developed technologies for vaccines and biological drugs can exhibit higher risk regarding drug stability and may require storage down to -80°C to maintain drug product shelf life and potency. While the compatibility of vial containers in deep cold storage conditions has a quite long and well documented history, prefillable syringe container compatibility in such conditions remains to be proven.
During this webinar, BD explores the challenges imposed by such conditions and shares outcomes on the following topics related to prefillable syringes in deep cold storage:
- Functional performance
- Sub-visible particles performance
- Container closure integrity